OBJECTIVES. To examine the independent relationship between plasma total homocysteine (tHcy) and microvascular and macrovascular complications. DESIGN. We performed a cross-sectional nested case-control study from the EURODIAB Prospective Complications Study. SETTING. A hospital-based multicentre study at 24 centres in 13 European countries. SUBJECTS. A total of 533 type 1 diabetic patients, diagnosed at <36 years of age. Cases (n=359) were defined as those with one or more complications of diabetes and control subjects (n=174) were all those with no evidence of any complication. Main outcome measures. Retinopathy, albumin excretion rate (AER), glomerular filtration rate (GFR) estimated by Cockcroft-Gault formula, hypertension and cardio...
BACKGROUND/AIMS: Coronary artery disease (CAD) is a major cause of mortality worldwide. Hyperhomocys...
Objective: The causal relationship between hyper-homocysteinemia and cardiovascular morbidity and mo...
blindness among patients with type 2 diabetes mellitus (DM). Hyperhomocysteinemia is a recently reco...
OBJECTIVES. To examine the independent relationship between plasma total homocysteine (tHcy) and mic...
Objectives. To examine the independent relationship between plasma total homocysteine (tHcy) and mic...
Background. Homocysteine is involved in a complex and dynamic system of vascular injury and repair a...
OBJECTIVE: To determine the range of plasma homocysteine values in a cohort of type 1 diabetic subje...
Cardiovascular disease is a major problem in diabetes, and risk factors presumably unrelated to diab...
Cardiovascular disease is a major problem in diabetes, and risk factors presumably unrelated to diab...
Patients with diabetes mellitus are prone to cardiovascular disease, and risk factors presumably unr...
The reactive vascular-injuring amino acid homocysteine was previously shown to be increased in plasm...
OBJECTIVE: The aim of this study was to determine the distribution of plasma total homocysteine (tHc...
Type 1 diabetes is associated with an increased riskof cardiovascular disease, which cannot be fully...
The reactive vascular-injuring amino acid homocysteine was measured in plasma samples from 79 well-c...
Objective— Homocysteine is an emerging risk factor for cardiovascular and nondiabetic ocular vaso-oc...
BACKGROUND/AIMS: Coronary artery disease (CAD) is a major cause of mortality worldwide. Hyperhomocys...
Objective: The causal relationship between hyper-homocysteinemia and cardiovascular morbidity and mo...
blindness among patients with type 2 diabetes mellitus (DM). Hyperhomocysteinemia is a recently reco...
OBJECTIVES. To examine the independent relationship between plasma total homocysteine (tHcy) and mic...
Objectives. To examine the independent relationship between plasma total homocysteine (tHcy) and mic...
Background. Homocysteine is involved in a complex and dynamic system of vascular injury and repair a...
OBJECTIVE: To determine the range of plasma homocysteine values in a cohort of type 1 diabetic subje...
Cardiovascular disease is a major problem in diabetes, and risk factors presumably unrelated to diab...
Cardiovascular disease is a major problem in diabetes, and risk factors presumably unrelated to diab...
Patients with diabetes mellitus are prone to cardiovascular disease, and risk factors presumably unr...
The reactive vascular-injuring amino acid homocysteine was previously shown to be increased in plasm...
OBJECTIVE: The aim of this study was to determine the distribution of plasma total homocysteine (tHc...
Type 1 diabetes is associated with an increased riskof cardiovascular disease, which cannot be fully...
The reactive vascular-injuring amino acid homocysteine was measured in plasma samples from 79 well-c...
Objective— Homocysteine is an emerging risk factor for cardiovascular and nondiabetic ocular vaso-oc...
BACKGROUND/AIMS: Coronary artery disease (CAD) is a major cause of mortality worldwide. Hyperhomocys...
Objective: The causal relationship between hyper-homocysteinemia and cardiovascular morbidity and mo...
blindness among patients with type 2 diabetes mellitus (DM). Hyperhomocysteinemia is a recently reco...